Stryker Co. (NYSE:SYK – Get Free Report) announced a quarterly dividend on Thursday, May 9th, Zacks reports. Stockholders of record on Friday, June 28th will be given a dividend of 0.80 per share by the medical technology company on Wednesday, July 31st. This represents a $3.20 annualized dividend and a dividend yield of 0.94%. The ex-dividend date is Friday, June 28th.
Stryker has increased its dividend by an average of 9.0% per year over the last three years and has increased its dividend annually for the last 31 consecutive years. Stryker has a payout ratio of 23.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Stryker to earn $13.38 per share next year, which means the company should continue to be able to cover its $3.20 annual dividend with an expected future payout ratio of 23.9%.
Stryker Stock Up 0.4 %
Stryker stock opened at $340.79 on Thursday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The firm has a market capitalization of $129.82 billion, a price-to-earnings ratio of 38.90, a price-to-earnings-growth ratio of 2.67 and a beta of 0.92. Stryker has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The stock’s fifty day moving average is $336.73 and its two-hundred day moving average is $332.95.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Roth Mkm increased their target price on Stryker from $348.00 to $405.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. The Goldman Sachs Group initiated coverage on Stryker in a research report on Thursday, May 30th. They issued a “neutral” rating and a $372.00 target price for the company. Royal Bank of Canada lifted their target price on Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a research report on Monday, April 15th. BTIG Research lifted their target price on Stryker from $366.00 to $369.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Finally, Stifel Nicolaus lifted their target price on Stryker from $350.00 to $375.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and an average price target of $370.58.
Check Out Our Latest Analysis on SYK
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Featured Stories
- Five stocks we like better than Stryker
- Basic Materials Stocks Investing
- Why Paychex Stock’s Dip is the Best Opportunity in Today’s Cycle
- What is the Nikkei 225 index?
- Any Pullback in Tech May Signal a Rotation into These 3 Sectors
- How to Invest in Blue Chip Stocks
- 3 Stocks to Watch: Oracle, Casey’s, FedEx Signal Big Gains
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.